IP Library Granted Patent US 7,091,006
Granted Patent B2
US 7,091,006 · App. 10/290,544 · Granted Aug 15, 2006

PGC-1β, a novel PGC-1 homologue and uses therefor

Assignee: Dana-Farber Cancer Institute, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,091,006
App. No.
10/290,544
Granted
Aug 15, 2006
Kind
B2
Abstract

The invention provides isolated nucleic acid molecules, designated PGC-1β nucleic acid molecules, which encode novel PGC-1 related coactivator molecules. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing PGC-1β nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a PGC-1β gene has been introduced or disrupted. The invention still further provides isolated PGC-1β proteins, fusion proteins, antigenic peptides and anti-PGC-1β antibodies. Diagnostic and therapeutic methods utilizing compositions of the invention are also provided.

Claims (12)

1. An isolated nucleic acid molecule selected from the group consisting of:

(a) a nucleic acid molecule comprising the nucleotide sequence set forth in SEQ ID NO: 4, or a full complement thereof; and

(b) a nucleic acid molecule comprising the nucleotide sequence set forth in SEQ ID NO: 6, or a full complement thereof.

2. An isolated nucleic acid molecule which encodes a polypeptide comprising the amino acid sequence set forth in SEQ ID NO:5.

3. An isolated nucleic acid molecule selected from the group consisting of:

a) a nucleic acid molecule comprising a nucleotide sequence which is at least 98% identical to the nucleotide sequence of SEQ ID NO:4 or 6, or a full complement thereof and wherein the nucleic acid molecule encodes a polypeptide with one or more of the following biological activities: modulates the activity of a nuclear receptor and/or NRF1, modulates brown adipose cell determination and/or differentiation, modulates mitochondrial activity and/or biogenesis or modulates fatty acid β-oxidation;

b) a nucleic acid molecule which encodes a polypeptide comprising an amino acid sequence at least about 98% identical to the amino acid sequence of SEQ ID NO:5 and wherein the encoded polypeptide maintains one or more of the following biological activities: modulates the activity of a nuclear receptor and/or NRF1, modulates brown adipose cell determination and/or differentiation, modulates mitochondrial activity and/or biogenesis or modulates fatty acid β-oxidation.

4. An isolated nucleic acid molecule comprising the nucleic acid molecule of any one of claims 1 , 2 , or 3 , and a nucleotide sequence encoding a heterologous polypeptide.

5. A vector comprising the nucleic acid molecule of any one of claims 1 , 2 , 3 .

6. The vector of claim 5 , which is an expression vector.

7. An isolated host cell transfected with the expression vector of claim 6 .

8. A method of producing a polypeptide comprising culturing the host cell of claim 7 in an appropriate culture medium to, thereby, produce the polypeptide.

Assignments (6)
CORRECTIVE ASSIGNMENT TO CORRECT THE APPLICATION NUMBER PREVIOUSLY RECORDED AT REEL: 013853 FRAME: 0393. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Oct 28, 2020
From: SPIEGELMAN, BRUCE M.; LIN, JIANDIE
To: DANA-FARBER CANCER INSTITUTE, INC.
Reel/Frame 054239/0422 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 22, 2019
From: SPIEGELMAN, BRUCE M.; LIN, JIANDIE
To: DANA-FARBER CANCER INSTITUTE, INC.
Reel/Frame 050785/0635 →
CONFIRMATORY LICENSE Recorded Nov 29, 2016
From: DANA-FARBER CANCER INST
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 040708/0335 →
CONFIRMATORY LICENSE Recorded Nov 29, 2016
From: DANA-FARBER CANCER INST
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 040708/0394 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 23, 2003
From: SPIEGELMAN, BRUCE M.; LIN, JIANDIE
To: DANA-FARBER CANCER INSTITUTE, INC.
Reel/Frame 014071/0086 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 17, 2003
From: SPIEGELMAN, BRUCE M.; LIN, JIANDIE
To: DANA-FARBER CANCER INSTITUTE, INC.
Reel/Frame 013853/0393 →
Continuity (2)
Provisional Application 6033812600 · Nov 9, 2001
Related Publication 20030124598A1 · Jul 3, 2003